Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Invested Capital for 3 consecutive years, with $9.2 million the latest figure, recorded in Q4 2025.

• Quarterly Invested Capital fell 11.43% year-over-year to $9.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.7 million (changed N/A YoY) and the FY2025 annual result came in at $9.2 million, down 10.0% from the prior year.
• Invested Capital climbed to $9.2 million in Q4 2025 per ZYBT's latest filing, from $27650.5 in the prior quarter.
• Over the last five years, Invested Capital for ZYBT reached as high as $11.1 million in Q4 2023 and fell as low as $27650.5 in Q2 2025.
• A 3-year average of $7.7 million and a median of $9.8 million in 2024 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2024 — Invested Capital dropped 6.56% — and 2025, when it decreased 11.43%.
• Year by year, Invested Capital stood at $11.1 million in 2023, then dropped by 6.56% to $10.4 million in 2024, then slipped by 11.43% to $9.2 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $9.2 million, $27650.5, and $10.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.